Exclusive Staphylococcus aureus throat carriage at-risk populations

Archives of Internal Medicine

Volumn 169, Issue 2, 2009, Pages 172-178

  Mertz, Dominik ^a   Frei, Reno ^a   Periat, Nadine ^a   Zimmerli, Melanie ^a   Battegay, Manuel ^a   Flückiger, Ursula ^a   Widmer, Andreas F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; DENTISTRY; DIAGNOSTIC ACCURACY; DISEASE CARRIER; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; STAPHYLOCOCCUS AUREUS; THROAT; THROAT CULTURE;

ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PHARYNX; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 58949099523     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2008.536     Document Type: Article

References (29)

1. Styers D, Sheehan D, Hogan P, Sahm D. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob. 2006;5:e2. http://www.pubmedcentral.nih.gov/articlerender.fcgi? tool=pubmed &pubmedid=16469106. Accessed October 6, 2008.
2. White A. Increased infection rates in heavy nasal carriers of 1 coagulase-positive staphylococci. Antimicrob Agents Chemother (Bethesda). 1963;30:667-670.
3. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Micro-biol Rev. 1997;10(3):505-520.
4. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364(9435):703-705.
5. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344(1):11-16.
6. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcusaureus infections. Lancet Infect Dis. 2005;5(12):751-762.
7. van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother. 2008;61(2):254-261.
8. Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med. 1968;279(9):441-448.
9. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41(suppl 4):S269-S272.
10. Moran GJ, Krishnadasan A, Gorwitz RJ, et al; EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
11. Gorwitz RJ, Kruszon-Moran D, McAllister SK, etal. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197(9):1226-1234.
12. Siegel J, Rhinehart E, Jackson M, Chiarello L. Management of Multidrug-Resistant Organisms in Healthcare Settings. Atlanta, GA: Centers for Disease Control and Prevention; 2006. http://www.cdc.gov/ncidod/dhqp/ guidelines.html. Accessed October 7, 2008.
13. Widmer AF, Mertz D, Frei R. Necessity of screening of both the nose and the throat to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit. J Clin Microbiol. 2008;46(2):e835. http://www.pubmedcentral.nih.gov/articlerender. fcgi?tool=pubmed &pubmedid=18252860. Accessed October 6, 2008.
14. Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev. 1963;27:56-71.
15. Marshall C, Spelman D. Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol. 2007;45(11):e3855. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool= pubmed &pubmedid=17728478. Accessed October 6, 2008.
16. Nilsson P, RipaT. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol. 2006;44(9):3334-3339.
17. Ringberg H, Cathrine Petersson A, Walder M, Hugo Johansson PJ. The throat: an importantsite forMRSA colonization. Scand J Infect Dis. 2006;38(10):888-893.
18. Mertz D, Frei R, Jaussi B, et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis. 2007;45(4):475-477.
19. Clinical Laboratory Standards Institute. Performance Standards forAntimicro-bial SusceptibilityTesting. Wayne, PA: Clinical Laboratory Standards Institute; 2005. DocumentM100-S15.
20. RobicsekA, BeaumontJL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008; 148(6):409-418.
21. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistantenterococci: position statementforthe JointSHEAand APIC Task Force. Am J Infect Control. 2007;35(2):73-85.
22. Harbarth S, Sax H, Fankhauser-Rodriguez C, Schrenzel J, Agostinho A, Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med. 2006;1 1 9(3):275.e1 5-275.e23. http://www.sciencedirect.com/science/article/B6TDC-4J9MXY7-K/2 /faa743536a58c440dae56058f4d143cb. Accessed January 10, 2008.
23. Harbarth S, Schrenzel J, Renzi G, Akakpo C, Ricou B. Is throat screening necessary to detect MRSA colonization upon admission? J Clin Microbiol. 2007; 45(3):1072-1073.
24. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193(2):172-179.
25. Harbarth S, Masuet-Aumatell C, Schrenzel J, etal. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin- resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care. 2006;10(1):eR25. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid= 16469125. Accessed October 6, 2008.
26. Wernitz MH, Keck S, Swidsinski S, SchulzS, VeitSK. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect. 2005;11(6):466-471.
27. Kluytmans J, van Leeuwen W, Goessens W, etal. Food-initiated outbreak of methicillin-resistant Staphylococcus aureus analyzed by pheno- and genotyping. J Clin Microbiol. 1995;33(5):1121-1128.
28. Grmek-Kosnik I, Ihan A, Dermota U, Rems M, Kosnik M, Jorn Kolmos H. Evaluation of separate vs pooled swab cultures, different media, broth enrichment and anatomical sites of screening for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. J Hosp Infect. 2005;61(2):155-161.
29. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer A. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus (MRSA) carriers. Infect Control Hosp Epidemiol. 2008;29(6):510-516.